Cargando…
Emerging targets for glioblastoma stem cell therapy
Glioblastoma multiforme (GBM), designated as World Health Organization (WHO) grade IV astrocytoma, is a lethal and therapy-resistant brain cancer comprised of several tumor cell subpopulations, including GBM stem cells (GSCs) which are believed to contribute to tumor recurrence following initial res...
Autores principales: | Safa, Ahmad R., Saadatzadeh, Mohammad Reza, Cohen-Gadol, Aaron A., Pollok, Karen E., Bijangi-Vishehsaraei, Khadijeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726830/ https://www.ncbi.nlm.nih.gov/pubmed/26616589 http://dx.doi.org/10.7555/JBR.30.20150100 |
Ejemplares similares
-
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs
por: Safa, Ahmad R., et al.
Publicado: (2015) -
c-FLIP, a Novel Biomarker for Cancer Prognosis, Immunosuppression, Alzheimer’s Disease, Chronic Obstructive Pulmonary Disease (COPD), and a Rationale Therapeutic Target
por: Safa, Ahmad R, et al.
Publicado: (2019) -
The Role of MDM2 in Promoting Genome Stability versus Instability
por: Saadatzadeh, M. Reza, et al.
Publicado: (2017) -
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
por: Barghi, Farinaz, et al.
Publicado: (2022) -
Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
por: Li, Kexin, et al.
Publicado: (2023)